ƽÌØÎå²»ÖÐ

AMR news page with globe on background and headlines from around the world

AMR Centre newsletter
For the latest in
AMR news & events

AMR Centre News

Ìý

Ìý


ƽÌØÎå²»ÖÐ Innovation Fund launches 4th edition
with major support from Desjardins

North America’s largest co-operative financial group to contribute $500,000 for entrepreneurial competition’s top-tier awards

ƽÌØÎå²»ÖÐ and Desjardins Group are teaming up to support research-based innovation. North America’s largest co-operative financial group will provide the ƽÌØÎå²»ÖÐ Innovation Fund (MIF) – the biggest entrepreneurial competition at ƽÌØÎå²»ÖР– with $500,000 over five years.


Four new clinical trials grants from the CIHR for RI-MUHC researchersÌý

The Government of Canada announced investments in 14 new clinical trials to support Canada’s response to major health threats and bolster the life sciences sector

One of the funded clinical trials includes Centre memberÌý: Biomarker-signature Supported Antibiotic Treatment Decisions in ICU (BAST-ICU).Ìý

Researchers at the RI-MUHC will lead four of the fourteen newly funded clinical trials. From left, Patrick Lawler, MD, Dick Menzies, MD, Ruth Sapir-Pichhadze, MD, PhD, Makeda Semret, MD


Antibiotic-Free Treatment for Infection? New Technology with Potential in the Fight Against Antimicrobial Resistance

microbesNew treatment under development by Professor Karine Auclair and Assistant Professor Andréanne Lupien could potentially treat intracellular infections without the need for traditional antibiotics. Supported by the ƽÌØÎå²»ÖÐ Innovation Fund (MIF) and the ƽÌØÎå²»ÖÐ Antimicrobial Resistance (AMR) Centre, the team hopes to bring this technology to the market.Ìý

Read about this developing technology


Five professors honoured as Montreal ambassadors

man holding glass globe awardƽÌØÎå²»ÖÐ is the only organization with multiple Palais des congrès honoureesÌý


Third running of the MIF turns focus to antimicrobial resistance

lab experiment with hands over Petri dish Innovation is alive and well at ƽÌØÎå²»ÖÐ! Six teams chosen from highly competitive field, as previous participants leverage their experience to secure their spot in new cohort.


MIF launches 3rd edition, offers new AMR award

superbug microbeTheÌýƽÌØÎå²»ÖÐ Innovation FundÌý(MIF) is returning for a third edition and is partnering with the ƽÌØÎå²»ÖÐ AMR CentreÌýto provide an additional $75,000 in funding to be distributed as a supplemental prize.Ìý


Getting things started at the ƽÌØÎå²»ÖÐ Antimicrobial ResistanceÌýCentre

Profile of Dr Dao NguyenRI-MUHC and ƽÌØÎå²»ÖÐ researchers join forces against a major global threat to human health.ÌýMobilizing in the fight against antimicrobial resistance (AMR), researchers from the Research Institute of the ƽÌØÎå²»ÖÐ Health Centre (RI-MUHC) and ƽÌØÎå²»ÖÐ have launched a new intensive care unit platform for infection research, with scientific seminars and symposia, funding programs and much more.

Ìý


MI4, Montreal’s powerhouse of infectious disease research, celebrates 5th anniversary

MI4 brings together over 250 researchers and 5,000 staff from a wide range of fields to find new solutions for some of humanity’s deadliest threats: tuberculosis, antimicrobial resistance, COVID-19 and many more. The group also studies immunity and how the immune system can be harnessed to fight infection.ÌýToday, MI4 has set its sights on a new global threat: antimicrobial resistance (AMR).

profile of 5 scientist involved in MI4

Ìý

ƽÌØÎå²»ÖÐ AMR Researcher Andrew Gonzalez Makes the Highly Cited Researchers 2021ÌýList

Biology professor and AMR associate antimicrobial resistance center member Andrew GonzalezAMR memberÌýAndrew Gonzalez was one of 14 ƽÌØÎå²»ÖÐ scientists who made the 2021 list of most highly cited researchers.Ìý The list is compiled yearly by Clarivate and includes the top cited authors within their respective fields.


Stamping out superbugs

As the threat of the pandemic begins to fade in some areas, researchers are turning their attention to another imminent crisis: antimicrobial resistance.

Dr Dao Nguyen and Dr Makeda Semret talk about the antibiotic resistance crisis

Image by Owen Egan/Joni Dufour.

Diana KwonÌý| 24 Sep 2021

During the last year and a half, the world’s attention has been focused squarely on SARS-CoV-2, the coronavirus that causes COVID-19. While deadly, this virus is only one of many pathogens that threaten our well-being. For many years, scientists have been warning about another microscopic menace: drug-resistant microbes.


ƽÌØÎå²»ÖÐ Health Centre Researcher Vivian Loo Receives the 2021 Peggy Lillis Foundation Innovator Award for Her Work With C.difficle

C.difficile bacteria under the microscope.  MUHC researcher Vivian Loo receives an Innovator Award for her research in C.difficile.Clostridioides difficile causes approximately 500 000 infections a year in the United States mostÌýoften developing following antibiotic treatment. As part of the US C.difficile Awareness month the Peggy Lillis Foundation held its virtual gala to raise awareness and recognize significant contributions in the field. One of three awardees was MUHC researcher Vivian Loo who received the Peggy Lillis Foundation Innovator Award.


ƽÌØÎå²»ÖÐ Researchers Solve the Largest Protein Crystal Structure Yet

Crystal structure of COA with bound substrateAMR members Albert Berghuis and Martin Schmeing and their teams have recently solved the crystal structure ofÌýtheÌýThermus thermophilusÌýribosome in complex with plazomicin at a resolution ofÌý3.27 Å.Ìý The structure was recently reported in .


Research Offers Insight in the Battle with Antibiotic Resistance

structural details of EreC, an enzyme responsible for macrolide resistanceƽÌØÎå²»ÖÐ researcher Albert Berghuis and his team reported structural details of EreC, anÌýenzyme responsible for macrolide resistance.Ìý The structure was published in .


New Antibiotic Resistance Centre Will Tackle Resistance Crisis

Dr. Dao Nguyen, Clinician-Scientist in the Respiratory Diseases Program at the Research Institute of the MUHCAntibiotic resistance is considered by the WHO to be one of the greatest threats facing mankind.Ìý With the creation of the Antimicrobial Research Centre, ƽÌØÎå²»ÖÐ Researchers will be at the forefront of the battle against antimicrobialÌýresistance in microorganisms.

Ìý

Ìý

Ìý

Back to top